Cleveland Clinic Taussig Cancer Institute

Taussig Cancer Institute is the hub for Cleveland Clinic Cancer Center.


 

Metastatic Colorectal Cancer: BRAFV600E / HER2 Are Predictive of Efficacy to Combination Targeted Therapies, POLE/POLD1 and High TMB Are Sensitive to CPis

852 views
December 10, 2019
Comments 0
Login to view comments. Click here to Login